How do you distinguish a back-of-the-pack runner on a blood-pressure medication that theoretically requires a medical exemption from a competitive age-group contender seeking an advantage
Materials and methods Participants A total of 33 adults with ASD and 52 neurotypical control adults were included in this study
Accompaniment, Design, and Research Carl DiSalvo, Professor, School of Interactive Computing, Georgia Tech Sept 18, 2025 12:00 p.m
TB-500 has been investigated for its ability to support neurological recovery and enhance oligodendrocyte differentiation.- BPC-157 has demonstrated neuroprotective potential in models of traumatic brain injury and dopaminergic system imbalance
Maqbool M, Ali A, Alderson PG, Mohamed MTM, Siddiqui Y, Zahid N
& Dominiczak, A